VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 76 of Oncotarget features Figure 2, "The identification of TTGM 5826 as a potential modulator of tTG conformation," by Katt, et al.
|
|
Table of Contents
News
|
| Gadd45 stress sensors in suppression of leukemia |
|
https://doi.org/10.18632/oncotarget.26154
|
| 34191-34192 |
Editorial
|
| CDK4/6 inhibitors in hormone receptorpositive human epidermal growth factor receptor 2 HER2negative metastatic breast cancer: Are we at the finish line |
|
https://doi.org/10.18632/oncotarget.26134
|
| 34193-34195 |
|
| Metastasisdirected therapy: a new standard for oligorecurrent prostate cancer |
|
https://doi.org/10.18632/oncotarget.26152
|
| 34196-34197 |
|
| The ubiquitinactivating enzyme UBA1 as a novel therapeutic target for AML |
|
https://doi.org/10.18632/oncotarget.26153
|
| 34198-34199 |
Research Papers
|
| Carnosol suppresses patientderived gastric tumor growth by targeting RSK2 |
|
https://doi.org/10.18632/oncotarget.24409
|
| 34200-34212 |
|
| Clearance of HBeAg and HBsAg of HBV in mice model by a recombinant HBV vaccine combined with GMCSF and IFNα as an effective therapeutic vaccine adjuvant |
|
https://doi.org/10.18632/oncotarget.25789
|
| 34213-34228 |
|
| Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profiles |
|
https://doi.org/10.18632/oncotarget.26026
|
| 34229-34239 |
|
| Heat shock protein 90 inhibitors overcome the resistance to Fmslike tyrosine kinase 3 inhibitors in acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.26045
|
| 34240-34258 |
|
| The role of AP1 in selfsufficient proliferation and migration of cancer cells and its potential impact on an autocrine/paracrine loop |
|
https://doi.org/10.18632/oncotarget.26047
|
| 34259-34278 |
|
| Spatiotemporal tumor heterogeneity in metastatic CRC tumors: a mutationalbased approach |
|
https://doi.org/10.18632/oncotarget.26081
|
| 34279-34288 |
|
| Molecular dynamics simulation reveals the possible druggable hotspots of USP7 |
|
https://doi.org/10.18632/oncotarget.26136
|
| 34289-34305 |
|
| Oncogenic driver FGFR3TACC3 is dependent on membrane trafficking and ERK signaling |
|
https://doi.org/10.18632/oncotarget.26142
|
| 34306-34319 |
|
| Overexpression of KDM5B/JARID1B is associated with poor prognosis in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.26144
|
| 34320-34335 |
|
| The efficacy of rechallenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study |
|
https://doi.org/10.18632/oncotarget.26149
|
| 34336-34346 |
|
| Vitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort study |
|
https://doi.org/10.18632/oncotarget.26151
|
| 34347-34356 |
|
| Functional characterization of phospholipase Cγ2 mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder |
|
https://doi.org/10.18632/oncotarget.26173
|
| 34357-34378 |
|
| A small molecule regulator of tissue transglutaminase conformation inhibits the malignant phenotype of cancer cells |
|
https://doi.org/10.18632/oncotarget.26193
|
| 34379-34397 |
Reviews
|
| Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia |
|
https://doi.org/10.18632/oncotarget.26146
|
| 34398-34412 |
|
| Genes involved in the regulation of different types of autophagy and their participation in cancer pathogenesis |
|
https://doi.org/10.18632/oncotarget.26126
|
| 34413-34428 |
|
| Prominent role of histone lysine demethylases in cancer epigenetics and therapy |
|
https://doi.org/10.18632/oncotarget.24319
|
| 34429-34448 |
Corrections
|
| Correction: Acute myeloid leukemia with t4;12q12;p13: an aggressive disease with frequent involvement of PDGFRA and ETV6 |
|
https://doi.org/10.18632/oncotarget.26205
|
| 34449-34449 |
Errata
|
| Erratum: Actinbinding protein alphaactinin 4 ACTN4 is a transcriptional coactivator of RelA/p65 subunit of NFkB |
|
https://doi.org/10.18632/oncotarget.26206
|
| 34450-34450 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
